SCHEMBL30976451

SCHEMBL30976451

CCn1nc(C(=O)N2CCN(C(=O)OC(C)(C)C)CC2)c2ccccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.56
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 6/20 0.53
DTYMK P23919 1/20 0.52
TSHR P16473 2/20 0.52
LMNA P02545 3/20 0.50
THRB P10828 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPT P10636 4/20 0.48
HTT P42858 3/20 0.48
GAA P10253 2/20 0.48
NPSR1 Q6W5P4 2/20 0.47
MAPK1 P28482 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47
ATM Q13315 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30976347 0.85 MEN1 (0.69) L3MBTL1ALDH1A1DTYMKTSHRLMNA
SCHEMBL30976354 0.80 ALDH1A1 (0.58) L3MBTL1KDM4EALDH1A1TSHRLMNA
SCHEMBL23966843 0.75 ALOX15 (0.51) DTYMKLMNAHTTCHRM2CHRM4
SCHEMBL13720683 0.74 LMNA (0.41) ALDH1A1DTYMKTSHRLMNAMEN1
SCHEMBL30976411 0.74 TP53 (0.56) L3MBTL1KDM4EALDH1A1TSHRLMNA
SCHEMBL30976334 0.74 POLB (0.54) L3MBTL1ALDH1A1DTYMKLMNAMEN1
SCHEMBL31199177 0.74 ALDH1A1 (0.59) L3MBTL1KDM4EALDH1A1TSHRLMNA
SCHEMBL30976476 0.72 MEN1 (0.51) L3MBTL1ALDH1A1DTYMKLMNAMEN1
SCHEMBL30976251 0.72 MEN1 (0.51) L3MBTL1ALDH1A1DTYMKLMNAMEN1
SCHEMBL30976241 0.72 MEN1 (0.50) L3MBTL1ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed